Kooman & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $304K | Sell |
390
-12
| -3% | -$9.35K | 0.1% | 39 |
|
|
2025
Q1 | $332K | Buy |
402
+28
| +7% | +$23.1K | 0.12% | 34 |
|
|
2024
Q4 | $289K | Sell |
374
-1
| -0.3% | -$772 | 0.1% | 38 |
|
|
2024
Q3 | $332K | Sell |
375
-11
| -3% | -$9.75K | 0.12% | 34 |
|
|
2024
Q2 | $349K | Sell |
386
-18
| -4% | -$16.3K | 0.14% | 33 |
|
|
2024
Q1 | $314K | Buy |
404
+10
| +3% | +$7.78K | 0.13% | 29 |
|
|
2023
Q4 | $230K | Sell |
394
-18
| -4% | -$10.5K | 0.1% | 37 |
|
|
2023
Q3 | $221K | Sell |
412
-35
| -8% | -$18.8K | 0.11% | 37 |
|
|
2023
Q2 | $210K | Buy |
+447
| New | +$210K | 0.1% | 40 |
|